EPCAM and colorectal carcinoma: The prevalence of EPCAM germline deletions in Korean patients with MSH2-deficient CRC (3%) from our cohort is lower than the previously reported prevalence of EPCAM germline deletions in MSH2-deficient CRCs in Western countries (up to 10%) [10, 11].